Long Covid
A Areas medical research research area page covering state of the field, key trials running, recent readouts and what is close to approval, alongside the 7
PET-Guided Strategy Enables Chemotherapy De-Escalation in HER2-Positive Breast Cancer
Long-term data from the phase II PHERGain trial shows a PET-guided, response-adapted strategy allowed many patients with HER2-positive early breast...
Regeneron and Sanofi Expand Antibody Alliance in $8 Billion Deal
Regeneron and Sanofi have expanded their long-standing collaboration with an $8 billion deal to co-develop four next-generation immunology drugs.
Lancet Series calls for reimagined maternal cardiovascular care
A new Lancet Series argues that cardiovascular care in pregnancy must shift from reacting to crises to anticipating and managing long-term risk.
Medical Groups Issue Independent Fall Vaccine Guidelines
Major U.S. medical societies have released independent guidelines for flu, Covid-19, and RSV vaccinations this winter.
FDA clears three updated COVID-19 vaccines
The FDA approved updated COVID-19 vaccines from Pfizer, Moderna, and Novavax. Moderna also raised $2.6 billion for its cancer drug business.
Lancet warns of new biosecurity risks
A Lancet editorial published on August 29, 2026, argues that political focus on COVID-19 origins is hindering preparedness for emerging biosecurity...
Federal Drug Pricing Program Deadline Looms for States
States face a September 30 deadline to decide whether to participate in a federal program offering 'most-favored nation' drug prices for Medicaid...